Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elad Sharon

Showing results (151-160 of 191) with videos related to

Pageof 20
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2026
Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2Niamh Coleman, Zihan Wei, A John Iafrate, et al.
Eclinicalmedicine|May 2, 2023
SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational studyJoshua A Hill, Michael J Martens, Jo-Anne H Young, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2024
Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesotheliomaAaron S Mansfield, Jun Vivien Yin, Penelope Bradbury, et al.
Journal for Immunotherapy of Cancer|April 21, 2021
Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinomaPaul Nghiem, Shailender Bhatia, Evan J Lipson, et al.
The Journal of Clinical Investigation|December 15, 2021
Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancersMark Yarchoan, Leslie Cope, Amanda N Ruggieri, et al.
JACC. Cardiooncology|February 19, 2025
Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology PrimerMarc P Bonaca, Ninian N Lang, Alice Chen, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2024
SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101)Joshua A Hill, Michael J Martens, Jo-Anne H Young, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 5, 2019
Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel DiseaseHamzah Abu-Sbeih, David M Faleck, Biagio Ricciuti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2024
SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational StudyJoshua A Hill, Michael J Martens, Jo-Anne H Young, et al.
Journal for Immunotherapy of Cancer|June 30, 2025
Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohortSandip Pravin Patel, Jillian Fisher, Young Kwang Chae, et al.
Pageof 20

Showing results (151-160 of 191) with videos related to

Sort By:
Pageof 20
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2026
Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2Niamh Coleman, Zihan Wei, A John Iafrate, et al.
Eclinicalmedicine|May 2, 2023
SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational studyJoshua A Hill, Michael J Martens, Jo-Anne H Young, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2024
Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesotheliomaAaron S Mansfield, Jun Vivien Yin, Penelope Bradbury, et al.
Journal for Immunotherapy of Cancer|April 21, 2021
Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinomaPaul Nghiem, Shailender Bhatia, Evan J Lipson, et al.
The Journal of Clinical Investigation|December 15, 2021
Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancersMark Yarchoan, Leslie Cope, Amanda N Ruggieri, et al.
JACC. Cardiooncology|February 19, 2025
Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology PrimerMarc P Bonaca, Ninian N Lang, Alice Chen, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2024
SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101)Joshua A Hill, Michael J Martens, Jo-Anne H Young, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 5, 2019
Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel DiseaseHamzah Abu-Sbeih, David M Faleck, Biagio Ricciuti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2024
SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational StudyJoshua A Hill, Michael J Martens, Jo-Anne H Young, et al.
Journal for Immunotherapy of Cancer|June 30, 2025
Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohortSandip Pravin Patel, Jillian Fisher, Young Kwang Chae, et al.
Pageof 20